Peptides corresponding to the heptad repeat sequence of human parainfluenza virus fusion protein are potent inhibitors of virus infection

被引:116
作者
Yao, QZ [1 ]
Compans, RW [1 ]
机构
[1] EMORY UNIV,SCH MED,DEPT MICROBIOL & IMMUNOL,ATLANTA,GA 30322
关键词
D O I
10.1006/viro.1996.0459
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
It has been suggested that a conserved heptad repeat region in paramyxovirus fusion (F) proteins is essential for viral fusion activity (Buckland et al., 1992; Sergel et al., 1994; Reitter et al., 1995). We have studied synthetic peptides containing the heptad repeat regions derived from the F proteins of human parainfluenza virus type 2 (P12) and type 3 (P13) for their function as potential inhibitors of virus-induced cell fusion as well as their effects on spread of viral infection. Two peptides containing sequences of heptad repeat B, adjacent to the transmembrane domain of the F protein, were synthesized for both P12 and P13 F proteins. We observed that the longer peptides [34 amino acids (a.a.) for P12F or 35 a.a. for P13F] which extend from heptad repeat B to the transmembrane domain showed complete inhibition of cell fusion induced by the respective virus as well as by the vaccinia-expressed F and HN proteins. The 50% effective concentration to inhibit virus-induced cell fusion was 2.1 mu M for P12 and 1.2 mu M for P13. Moreover, the inhibitory effects of each peptide on virus-induced cell fusion were found to be virus type-specific. These peptides were found to also inhibit viral entry and to prevent plaque formation when mixed with the virus inoculum. Furthermore, the peptides caused a reduction in virus yield when assayed 48 hr after low m.o.i. infection and in the size of viral plaques when added to the overlay. Shorter peptides (21 a.a. for P12F or 24 a.a. for P13F) which correspond to the partial sequence of heptad repeat a for P12F and the entire heptad repeat B for P13F showed partial inhibition of P12- or P13-induced cell fusion. These results indicate that peptides containing the heptad repeat a sequence have the potential to inhibit virus-induced cell fusion, virus entry, and spread of virus infection. (C) 1996 Academic Press, Inc.
引用
收藏
页码:103 / 112
页数:10
相关论文
共 57 条
[31]  
MORRISON T, 1991, PARAMYXOVIRUSES, P347
[32]   MEMBRANE-BOUND ANTIVIRAL ANTIBODIES AS RECEPTORS FOR SENDAI VIRIONS IN RECEPTOR-DEPLETED ERYTHROCYTES [J].
NUSSBAUM, O ;
ZAKAI, N ;
LOYTER, A .
VIROLOGY, 1984, 138 (02) :185-197
[33]   EVIDENCE THAT THE LEUCINE ZIPPER IS A COILED COIL [J].
OSHEA, EK ;
RUTKOWSKI, R ;
KIM, PS .
SCIENCE, 1989, 243 (4890) :538-542
[34]   ANALYSIS OF THE RELATIONSHIP BETWEEN CLEAVABILITY OF A PARAMYXOVIRUS FUSION PROTEIN AND LENGTH OF THE CONNECTING PEPTIDE [J].
PATERSON, RG ;
SHAUGHNESSY, MA ;
LAMB, RA .
JOURNAL OF VIROLOGY, 1989, 63 (03) :1293-1301
[35]  
PORTNER A, 1987, VIROLOGY, V156, P61
[36]   A SYNTHETIC PEPTIDE CORRESPONDING TO A CONSERVED HEPTAD REPEAT DOMAIN IS A POTENT INHIBITOR OF SENDAI VIRUS-CELL FUSION - AN EMERGING SIMILARITY WITH FUNCTIONAL DOMAINS OF OTHER VIRUSES [J].
RAPAPORT, D ;
OVADIA, M ;
SHAI, Y .
EMBO JOURNAL, 1995, 14 (22) :5524-5531
[37]   MUTATIONAL ANALYSIS OF THE LEUCINE-ZIPPER MOTIF IN THE NEWCASTLE-DISEASE VIRUS FUSION PROTEIN [J].
REITTER, JN ;
SERGEL, T ;
MORRISON, TG .
JOURNAL OF VIROLOGY, 1995, 69 (10) :5995-6004
[38]   STUDIES ON THE STRUCTURE OF THE INFLUENZA-VIRUS HEMAGGLUTININ AT THE PH OF MEMBRANE-FUSION [J].
RUIGROK, RWH ;
AITKEN, A ;
CALDER, LJ ;
MARTIN, SR ;
SKEHEL, JJ ;
WHARTON, SA ;
WEIS, W ;
WILEY, DC .
JOURNAL OF GENERAL VIROLOGY, 1988, 69 :2785-2795
[39]   IDENTIFICATION OF BIOLOGICAL-ACTIVITIES OF PARAMYXOVIRUS GLYCOPROTEINS - ACTIVATION OF CELL-FUSION, HEMOLYSIS, AND INFECTIVITY BY PROTEOLYTIC CLEAVAGE OF AN INACTIVE PRECURSOR PROTEIN OF SENDAI VIRUS [J].
SCHEID, A ;
CHOPPIN, PW .
VIROLOGY, 1974, 57 (02) :475-490
[40]   THE ATTACHMENT FUNCTION OF THE NEWCASTLE-DISEASE VIRUS HEMAGGLUTININ-NEURAMINIDASE PROTEIN CAN BE SEPARATED FROM FUSION PROMOTION BY MUTATION [J].
SERGEL, T ;
MCGINNES, LW ;
PEEPLES, ME ;
MORRISON, TG .
VIROLOGY, 1993, 193 (02) :717-726